Development of tachyphylaxis to the antilipolytic, hypoglycemic agent, 5-methylpyrazole-3-carboxylic acid, U-19425.
D000315:Adrenalectomy; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism*; D005230:Fatty Acids, Nonesterified / Q000097:blood* / Q000378:metabolism; D007016:Hypophysectomy; D008297:Male; D011720:Pyrazoles / Q000494:pharmacology*; D051381:Rats; D013618:Tachyphylaxis / Q000187:drug effects*
D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D011720:Pyrazoles